Aveanna Healthcare (NASDAQ:AVAH) Hits New 1-Year High – What’s Next?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $14.05 and last traded at $14.02, with a volume of 3133106 shares traded. The stock had previously closed at $13.66.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. Royal Bank Of Canada raised their price objective on Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a research report on Monday, August 24th. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $10.00 to $11.00 in a report on Friday, May 15th. UBS Group upped their target price on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a research report on Friday, August 14th. Finally, Raymond James Financial increased their price target on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research note on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $13.50.

Aveanna Healthcare Price Performance

The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47. The company has a market cap of $3.07 billion, a PE ratio of 11.46, a P/E/G ratio of 0.88 and a beta of 1.97. The firm has a 50 day moving average of $11.09 and a two-hundred day moving average of $8.49.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%.The business had revenue of $670.48 million during the quarter, compared to analysts’ expectations of $638.61 million. Research analysts predict that Aveanna Healthcare Holdings Inc. will post 0.75 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of the company’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $143,704,885.50. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, major shareholder Robert Williams, Jr. sold 14,500,002 shares of the firm’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $166,750,023.00. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 59,904,505 shares of company stock worth $649,301,514 in the last quarter. Corporate insiders own 5.30% of the company’s stock.

Institutional Investors Weigh In On Aveanna Healthcare

A number of institutional investors have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd raised its holdings in Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after acquiring an additional 2,400 shares during the last quarter. C M Bidwell & Associates Ltd. purchased a new stake in Aveanna Healthcare during the 2nd quarter valued at $69,000. Summit Securities Group LLC bought a new stake in shares of Aveanna Healthcare in the 1st quarter worth $53,000. Quantbot Technologies LP bought a new stake in shares of Aveanna Healthcare in the 2nd quarter worth $43,000. Finally, Freestone Grove Partners LP purchased a new position in shares of Aveanna Healthcare in the second quarter worth $73,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.